Institute of Integrated Research, Institute of Science Tokyo
Department of Advanced Nanomedical Engineering,
Medical Research Laboratory
Junichi ISHIKAWA, M.D., Ph.D.
Project Assistant Professor
E-mail:
Research Keywords
Drug delivery system (DDS), mRNA vaccine, Autoimmune disease
Biography
Education
| 2015.3 | M.D. School of Medicine, Chiba University, Chiba, Japan |
| 2023.3 | Ph.D. in Medicine. Graduate School of Medicine, Chiba University, Chiba, Japan (Leading Graduate School at Chiba University) |
Research History
| 2023.4- 2023.9 |
Research Fellow, Department of Allergy and Clinical immunology, Graduate School of Medicine, Chiba University, Chiba, Japan |
| 2023.10- 2024.6 |
Project Assistant Professor, Department of Allergy and Clinical immunology, Graduate School of Medicine, Chiba University, Chiba, Japan |
| 2024.7- | Project Assistant Professor, Department of Advanced Nanomedical Engineering, Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo (former name Tokyo Medical and Dental University) |
Clinical Training
| 2015.4- 2017.3 |
Junior Resident, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan |
| 2017.4- 2018.3 |
Senior Resident, Clinical Immunology, Yokohama Rousai Hospital, Kanagawa, Japan |
| 2018.4- 2019.3 |
Senior Resident, Internal Medicine, Japanese Red Cross Narita Hospital, Chiba, Japan |
| 2019.4- 2020.3 |
Senior Resident, Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan |
| 2020.4- 2024.6 |
Clinical Fellow, Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan |
Achievements
Publications
- Ishikawa J, Suto A, Abe K, Hayashi Y, Suga K, Tanaka S, Kageyama T, Iwata A, Suzuki K, Suzuki K, Nakajima H. IL-21 is required for the maintenance and pathogenesis of murine Vγ4+ IL-17-producing γδT cells. Front Immunol. 14:1211620. (2023)
- Suga K, Suto A, Tanaka S, Sugawara Y, Kageyama T, Ishikawa J, Sanayama Y, Ikeda K, Furuta S, Kagami S, Iwata A, Hirose K, Suzuki K, Ohara O, Nakajima H. TAp63, a methotrexate target in CD4+ T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis. JCI Insight. 8(10):e164778. (2023)
- Ida T, Furuta S, Takayama A, Tamura J, Hayashi Y, Abe K, Kurihara S, Ishikawa J, Iwamoto T, Ikeda K, Suzuki K, Nakajima H. Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis. RMD Open. 9(1):e002795. (2023)
- Hattori K, Tanaka S, Ishikawa J, Yabe Y, Iwamoto T, Furuta S, Ikeda K, Suzuki K, Nakajima H. Visceral disseminated varicella zoster virus infection during non-intensive maintenance therapy in a patient with systemic lupus erythematosus. Mod Rheumatol Case Rep. 7(1):57–59. (2023)
- Suzuki K, Suzuki K, Yabe Y, Iida K, Ishikawa J, Makita S, Kageyama T, Iwamoto T, Tanaka S, Yokota M, Iwata A, Suto A, Nakajima H. NF-κB1 Contributes to Imiquimod-Induced Psoriasis-Like Skin Inflammation by Inducing Vγ4+Vδ4+ γδT17 Cells. J Invest Dermatol. 142(6):1639–1649.e5 (2021)
- Abe K, Ishikawa Y, Ishikawa J, Fujiwara M, Kita Y. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab. Immunol Med. 42(4):185–188 (2019)
- Ishikawa Y, Hattori K, Ishikawa J, Fujiwara M, Kita Y. Refractory Sjögren’s syndrome myelopathy successfully treated with subcutaneous tocilizumab: A case report. Medicine (Baltimore). 98(27):e16285 (2019)
- Ishikawa Y, Kasuya T, Ishikawa J, Fujiwara M, Kita Y. A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus. Ther Clin Risk Manag. 14:1149–1153. (2018)
Books
- Ishikawa J, Suto A, Nakajima H. “The role of γδT17 cells in their differentiation and proliferation, and in the development of autoimmune diseases”. Clinical Immunology and Allergology vol. 81 No.4, Tokyo, KAGAKU-HYORONSHA, 2024, p. 366-372, ISSN:1881-1930
Awards
| 2024.6 | Young Scientist Award, the 16th Chiba Medical Society Award |
| 2023.5 | Young Scientist Award, Japanese Society for Interferon and Cytokine Research 2023 Joint Symposium |
| 2022.12 | Best Poster Award at the 51st Annal Meeting of the Japanese Society for Immunology |
| 2021.3 | Excellent LGS Student Award, Leading Graduate School, Chiba University |
Research Fundings
| 2023-2025 | JSPS, KAKENHI, Grant-in-Aid for Young Scientists (PI) |
Medical Certification
| 2015 | Japanese National Board of Medicine |
| 2018 | Board Certified in Internal Medicine |
| 2022 | Board Certified in Rheumatologist |
| 2023 | Board Certified in Senior Rheumatologist |
Memberships
- Japanese Society of Internal Medicine
- Japan College of Rheumatology
- Japanese Society of Allergology
- The Japanese Society for Immunology
- The Japanese Society of Clinical Immunology
- Japanese Cytokine Society
- The Japan Society of Drug Delivery System